http://www.cnr.it/ontology/cnr/individuo/prodotto/ID62780

Folic acid and congenital malformation: scientific evidence and public health strategies (Articolo in rivista)

Type

Label

Folic acid and congenital malformation: scientific evidence and public health strategies (Articolo in rivista) (literal)

Anno

Alternative label

1Salerno P.; 2Bianchi F.; 2Pierini A.; 1Baldi F.; 1Carbone P.; 1Mantovani A.; 1Taruscio D. (2008)
Folic acid and congenital malformation: scientific evidence and public health strategies
in Annali di igiene medicina preventiva e di comunità; Società Editrice Universo, Roma (Italia)
(literal)

Http://www.cnr.it/ontology/cnr/pubblicazioni.owl#autori

1Salerno P.; 2Bianchi F.; 2Pierini A.; 1Baldi F.; 1Carbone P.; 1Mantovani A.; 1Taruscio D. (literal)

Pagina inizio

Pagina fine

Http://www.cnr.it/ontology/cnr/pubblicazioni.owl#url

Http://www.cnr.it/ontology/cnr/pubblicazioni.owl#numeroVolume

Rivista

Http://www.cnr.it/ontology/cnr/pubblicazioni.owl#note

In: Annali di Igiene, vol. 20 (6) pp. 519 - 530. Società Editrice Universo s.r.l. Roma, 2008. (literal)

Http://www.cnr.it/ontology/cnr/pubblicazioni.owl#pagineTotali

Http://www.cnr.it/ontology/cnr/pubblicazioni.owl#numeroFascicolo

Http://www.cnr.it/ontology/cnr/pubblicazioni.owl#affiliazioni

1Centro Nazionale Malattie Rare, Istituto Superiore di Sanità, Roma; 2CNR-IFC, Pisa (literal)

Titolo

Folic acid and congenital malformation: scientific evidence and public health strategies (literal)

Abstract

In Italy at least 3% of babies are born with some congenital malformation. The intake of folic acid (FA) prior to conception and during the early stages of pregnancy plays an important role in preventing neural tube defects, severe anomalies of brain embryogenesis, and other malformations such as cardiac and urinary tract anomalies, oro-facial clefts and limb reduction defects. The Italian Network for Folic Acid Promotion, coordinated by the National Center on Rare Diseases of the Italian National Institute of Health, has elaborated and diffused a recommendation for the periconceptional FA supplementation: \"Women of child-bearing age, are recommended to consume 0,4 mg/day of FA, to reduce the risk of congenital defects. The intake of folic acid should start at least one month before the conception and should continue for the first quarter of pregnancy\". This paper discusses various strategies in order to promote AF intake during periconceptional period. Food fortification, adopted in several Countries such as USA, has arisen concerns about the risk of an excessive FA intake which may lead to adverse effect such as tumour promotion. Currently, periconceptional supplementation and healthy dietary habits promotion appear to be the most effective strategies. (literal)

Editore